Track: Neuro-Oncology

Neuro-Oncology

Neuro-oncology session will focus on the latest advancements and challenges in the field of neuro-oncology, which deals with cancers of the central nervous system. Experts will discuss recent research findings related to gliomas, meningiomas, brain metastases, and spinal cord tumors. Emphasis will be placed on innovative diagnostic methods, the integration of advanced imaging techniques, and the significance of molecular profiling in guiding treatment strategies.

1. Glioblastoma (GBM)
This sub-session will delve into the latest research, diagnostic approaches, and treatment options for glioblastoma, a highly aggressive brain tumor. Discussions will cover innovative surgical techniques, targeted therapies, and emerging clinical trials to enhance patient outcomes.

2. Meningiomas
Explore the latest research and treatment strategies for meningiomas, the most common primary brain tumors. Meningiomas sub-session will cover diagnostic approaches, surgical techniques, and emerging therapies, focusing on improving patient outcomes and advancing clinical care in neuro-oncology.

3. Astrocytomas
This sub-session will delve into the latest research and treatment strategies for astrocytomas, a common type of brain tumor. Key topics include advancements in diagnosis, molecular characteristics, targeted therapies, and patient management for better outcomes.

4. Oligodendrogliomas
Explore the latest research and treatment options for oligodendrogliomas, a rare type of brain tumor. Oligodendrogliomas sub-session will cover advances in diagnosis, molecular genetics, targeted therapies, and strategies for improving patient outcomes and survival rates.

5. Medulloblastomas
This sub-session will cover recent insights into medulloblastomas, the most common malignant brain tumors in children. Topics include advances in early detection, genetic profiling, targeted treatments, and emerging therapies, enhancing understanding and improving outcomes for affected patients.

6. Primary CNS Lymphoma (PCNSL)
This sub-session will explore the unique challenges of diagnosing and treating primary CNS lymphoma, a rare and aggressive cancer of the brain and spinal cord. Key topics include innovative therapies, recent research findings, and patient management strategies.